WQS-32765-45161
4 vaccinations
4 coded responses
36 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 741 / OK
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Recovering from an allergic reaction that may be unrelatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
- 2020-12-23
-
2020-12-30
Survey response — day 14, dose 1MedDRA: Anaphylactic reaction, Hypersensitivity — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: New allergy causing anaphylaxisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-01-09
- 2021-01-11
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-14
-
2021-01-20
Call successfulOther
- 2021-01-21
- 2021-01-28
-
2021-02-04
Survey response — day 28, dose 2MedDRA: Pre-existing disease, Seasonal allergy, Sinus disorder — Feeling: FairFree text: Sinus issues, likely from seasonal allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-04-10
- 2021-07-09
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-05
- 2021-10-14
- 2021-10-22
- 2021-10-26
- 2021-11-02
- 2021-11-10
- 2021-12-28
-
2022-03-29
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-30
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-06-01
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-06-29
- 2022-07-06
- 2022-07-13
- 2022-09-02
- 2022-11-30
- 2023-06-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-06-01 | Pfizer-BioNTech | Tetanus |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-30 | Successful 2021-01-20 |
Other |
| 2022-03-29 | Successful 2022-03-30 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Recovering from an allergic reaction that may be unrelated
Release 1 — day 14, dose 1
Symptoms: New allergy causing anaphylaxis
Release 3 — day 28, dose 2
Symptoms: Sinus issues, likely from seasonal allergies.
Release 11 — 6 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaphylactic reaction | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Seasonal allergy | ○ | ✓ | ○ |
| SD | Sinus disorder | ✓ | · | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release